DaVita Inc. $DVA Shares Purchased by Royal Bank of Canada

Key Points

• Royal Bank of Canada increased its holdings in DaVita Inc. by 12.0% during the 1st quarter, acquiring an additional 24,568 shares, bringing its total ownership to 228,624 shares valued at approximately $34.97 million.
• Wall Street analysts have shown a mixed outlook on DaVita, with ratings ranging from "hold" to "buy," and a consensus price target of $164.00 highlighted by various research firms.
• In its most recent earnings report, DaVita reported $2.95 EPS, exceeding expectations, and anticipates earnings for FY 2025 to be between 10.200-11.300 EPS.

Royal Bank of Canada grew its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 12.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 228,624 shares of the company's stock after buying an additional 24,568 shares during the period. Royal Bank of Canada owned 0.30% of DaVita worth $34,972,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Invesco Ltd. raised its position in shares of DaVita by 3.4% in the first quarter. Invesco Ltd. now owns 1,642,947 shares of the company's stock valued at $251,322,000 after buying an additional 53,402 shares during the last quarter. Northern Trust Corp raised its position in shares of DaVita by 20.2% in the first quarter. Northern Trust Corp now owns 890,632 shares of the company's stock valued at $136,240,000 after buying an additional 149,858 shares during the last quarter. Gates Capital Management Inc. raised its position in shares of DaVita by 0.7% in the first quarter. Gates Capital Management Inc. now owns 722,205 shares of the company's stock valued at $110,476,000 after buying an additional 4,698 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of DaVita by 14.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock valued at $69,697,000 after buying an additional 57,386 shares during the last quarter. Finally, Epoch Investment Partners Inc. raised its position in shares of DaVita by 10.7% in the first quarter. Epoch Investment Partners Inc. now owns 407,921 shares of the company's stock valued at $62,400,000 after buying an additional 39,485 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DVA shares. Barclays reduced their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research report on Thursday, August 7th. Bank of America dropped their price objective on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a report on Wednesday. Truist Financial set a $148.00 price objective on shares of DaVita in a report on Friday, August 8th. Finally, Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Reduce" and a consensus target price of $158.00.

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider owned 26,038 shares of the company's stock, valued at approximately $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.50% of the company's stock.

DaVita Trading Down 0.1%

DVA stock traded down $0.16 during mid-day trading on Friday, hitting $133.08. 481,674 shares of the company were exchanged, compared to its average volume of 673,038. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The firm has a market capitalization of $9.52 billion, a P/E ratio of 13.09, a PEG ratio of 0.95 and a beta of 1.13. The business has a fifty day simple moving average of $138.45 and a 200-day simple moving average of $141.54. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. DaVita's revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.